BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21058495)

  • 1. Advancements in the control of genital human papillomavirus infections and related diseases: highlighting Australia's role.
    Garland SM; Brotherton JM; Fairley CK; Gertig DM; Saville M
    Sex Health; 2010 Sep; 7(3):227-9. PubMed ID: 21058495
    [No Abstract]   [Full Text] [Related]  

  • 2. For debate: that Australia should continue using the quadrivalent vaccine.
    Wain G
    Sex Health; 2010 Sep; 7(3):235-7. PubMed ID: 21058496
    [No Abstract]   [Full Text] [Related]  

  • 3. For debate: that Australia should consider changing to the bivalent vaccine.
    Stern PL
    Sex Health; 2010 Sep; 7(3):238-41. PubMed ID: 21058497
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on opinion pieces re Australian human papillomavirus vaccine policy.
    McIntyre P
    Sex Health; 2010 Sep; 7(3):242-3. PubMed ID: 21058498
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current immunization committee includes vaccination against human papillomaviruses in the immunization schedule].
    Kinderkrankenschwester; 2007 May; 26(5):205. PubMed ID: 17550093
    [No Abstract]   [Full Text] [Related]  

  • 6. Cervical cancer vaccine development.
    Frazer IH
    Sex Health; 2010 Sep; 7(3):230-4. PubMed ID: 20719210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytology and DNA HPV-testing in the era of HPV-vaccine].
    Spaczyński M; Malkowska-Walczak B; Nowak-Markwitz E
    Ginekol Pol; 2007 Sep; 78(9):696-700. PubMed ID: 18159823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What can surveillance of genital warts tell us?
    Fairley CK; Donovan B
    Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low rates of free human papillomavirus vaccine uptake among young women.
    Moore GR; Crosby RA; Young A; Charnigo R
    Sex Health; 2010 Sep; 7(3):287-90. PubMed ID: 20719216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA
    Clin Obstet Gynecol; 2008 Sep; 51(3):527-32. PubMed ID: 18677145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine.
    Brotherton JM; Fairley CK; Garland SM; Gertig D; Saville M
    Sex Health; 2010 Sep; 7(3):397-8. PubMed ID: 21058499
    [No Abstract]   [Full Text] [Related]  

  • 13. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
    Vetter KM; Geller SE
    J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
    Pitts MK; Heywood W; Ryall R; Smith AM; Shelley JM; Richters J; Simpson JM
    Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance.
    Gold MS; McIntyre P
    Sex Health; 2010 Sep; 7(3):320-4. PubMed ID: 20719221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV vaccination and the prevention of cervical cancer: the long road ahead.
    Markman M
    J Womens Health (Larchmt); 2007 Nov; 16(9):1366-7. PubMed ID: 18001194
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of the human papillomavirus vaccine].
    Coquin Y; Guyot S; Le Quellec-Nathan M; Houssin D
    Rev Prat; 2006 Nov; 56(17):1861-2. PubMed ID: 17243380
    [No Abstract]   [Full Text] [Related]  

  • 18. Human papillomavirus vaccine acceptability among a national sample of adult women in the USA.
    Stupiansky NW; Rosenthal SL; Wiehe SE; Zimet GD
    Sex Health; 2010 Sep; 7(3):304-9. PubMed ID: 20719219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program.
    Brotherton JM; Leask J; Jackson C; McCaffery K; Trevena LJ
    Sex Health; 2010 Sep; 7(3):291-8. PubMed ID: 20719217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccination against human papillomaviridae. Expert correspondence no. 18 of 29 December 2006].
    Kommission Qualitätssicherung der Schweizerischen Gesellschaft für Gynäkologie und Geburtshilfe
    Gynakol Geburtshilfliche Rundsch; 2007; 47(2):101-2. PubMed ID: 17440273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.